Thus, the tumor-suppressive effects of SBSPON, at least partially, were achieved through suppressing the phosphorylation of AKT by inhibiting the membrane translocation of HSPA5 (Fig. 6), thereby inhibiting HSPA5's promoting effect on tumors. This evidence concerns the gene AKT1 and neoplasm.